Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

AIRDUO DIGIHALER

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Standard Dose
0.232MG/INH;EQ 0.014MG BASE/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AIRDUO DIGIHALER is listed in Drugs@FDA under application 208799 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Form and strength POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH Sponsor TEVA PHARM Submission history Latest submission status date: 2023-11-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview AIRDUO DIGIHALER is listed in Drugs@FDA under application 208799 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Form and strength POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH Sponsor TEVA PHARM Submission history Latest submission status date: 2023-11-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.